Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lethargic Depression Study
NCT00064467Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in major depressive disorder (MDD), sponsored by GSK. Started Jun 2003; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00064467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064467.